2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on HER2+ NSCLC: Did Trastuzumab Deruxtecan Demonstrate Favorable Clinical Activity?

401 views
September 22, 2020
Comments 0
Login to view comments. Click here to Login